Source: Journal of Experimental and Clinical Cancer Research. Unidades: SVOI, FMRP
Subjects: ALCALOIDES, ENDOTÉLIO VASCULAR, LEUCEMIA MIELOIDE, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSIS, Patricia A et al. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, v. 34, n. ju, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13046-015-0181-2. Acesso em: 16 nov. 2024.APA
Assis, P. A., Figueiredo-Pontes, L. L. de, Lima, A. S. G., Leão, V., Cândido, L. A., Pintão, C. T., et al. (2015). Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, 34( ju). doi:10.1186/s13046-015-0181-2NLM
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s13046-015-0181-2Vancouver
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s13046-015-0181-2
